LR Health & Beauty SE / NO0013149658

Disclosure of an inside information according to Art. 17 of the Regulation (EU) No. 596/2014 (Market Abuse Regulation – MAR)

LR HEALTH & BEAUTY SE RECEIVES SUPPORTING VOTING INTENTIONS BY 69.57% OF THE ADJUSTED NOMINAL AMOUNT FOR TEMPORARY WAIVERS UNDER THE 2024/2028 BONDS

Ahlen, 25 November 2025 – Today, LR Health & Beauty SE (the “Company”) was informed that bondholders representing approximately 69.57% of the adjusted nominal amount of the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bonds”) had expressed their intention to vote in favour of the temporary waivers, relating to postponement of interest payments and non-compliance with the maintenance test (including the leverage covenant) for a period up to and including 28 February 2026, that were requested in the Written Procedure initiated by the Company on 14 November 2025 under the terms and conditions of the Bonds (the “Written Procedure”).

Under the Written Procedure, a quorum of at least 50% of the adjusted nominal amount of the Bonds and a voting majority of at least 66.67% (two-thirds majority) of the adjusted nominal amount of the holders of the Bonds participating in the Written Procedure is required. Deadline for voting is 15:00 hrs CET on 28 November 2025.

For further information regarding the Written Procedure, please refer to the notice of the Written Procedure which is accessible on the Company’s website at https://ir.lrworld.com/en/bond/.


IR contact:

cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de